School of Medicine


Showing 121-140 of 144 Results

  • Konstantina M. Stankovic, MD, PhD, FACS

    Konstantina M. Stankovic, MD, PhD, FACS

    Bertarelli Foundation Professor and Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsOur investigative efforts are organized along 3 research thrusts:
    1. Vestibular schwannoma: uncovering mechanisms of sensorineural hearing loss (SNHL) and identifying better therapies;
    2. High-resolution imaging of the inner ear;
    3. Novel sensing of and therapies for SNHL.
    Given the complex, multifaceted nature of these problems, our approach to them involves domain-specific customization and fusion of tools from molecular biology, systems neuroscience, biotechnology and otologic surgery.

  • Gary K. Steinberg, MD, PhD

    Gary K. Steinberg, MD, PhD

    Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology

    Current Research and Scholarly InterestsOur laboratory investigates the pathophysiology and treatment of cerebral ischemia, and methods to restore neurologic function after stroke. Treatment strategies include brain hypothermia, stem cell transplantation and optogenetic stimulation. Our clinical research develops innovative surgical, endovascular and radiosurgical approaches for treating difficult intracranial aneurysms, complex vascular malformations and occlusive disease, including Moyamoya disease, as well as stem cell transplant.

  • Thomas Sudhof

    Thomas Sudhof

    Avram Goldstein Professor in the School of Medicine, Professor of Neurosurgery and, by courtesy, of Neurology and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsInformation transfer at synapses mediates information processing in brain, and is impaired in many brain diseases. Thomas Südhof is interested in how synapses are formed, how presynaptic terminals release neurotransmitters at synapses, and how synapses become dysfunctional in diseases such as autism or Alzheimer's disease. To address these questions, Südhof's laboratory employs approaches ranging from biophysical studies to the electrophysiological and behavioral analyses of mutant mice.

  • Peter Tass

    Peter Tass

    Professor of Neurosurgery

    BioDr. Peter Tass investigates and develops neuromodulation techniques for understanding and treating neurologic conditions such as Parkinson’s disease, epilepsy, dysfunction following stroke and tinnitus. He creates invasive and non-invasive therapeutic procedures by means of comprehensive computational neuroscience studies and advanced data analysis techniques. The computational neuroscience studies guide experiments that use clinical electrophysiology measures, such as high density EEG recordings and MRI imaging, and various outcome measures. He has pioneered a neuromodulation approach based on thorough computational modelling that employs dynamic self-organization, plasticity and other neuromodulation principles to produce sustained effects after stimulation. To investigate stimulation effects and disease-related brain activity, he focuses on the development of stimulation methods that cause a sustained neural desynchronization by an unlearning of abnormal synaptic interactions. He also performs and contributes to pre-clinical and clinical research in related areas.

  • Nicholas Telischak

    Nicholas Telischak

    Clinical Associate Professor, Radiology
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Nick Telischak is a neurointerventional surgeon (neurointerventional radiologist) who specializes in the diagnosis and treatment of stroke, brain aneurysms, brain arteriovenous malformations, brain and spinal dural arteriovenous fistulae, carotid artery stenosis, vertebral body compression fractures, spinal metastases, axial back pain, and congenital vascular malformations. Dr. Telischak treats all of these conditions using minimally-invasive, image-guided procedures and state-of-the-art technology.

  • Suzanne Tharin

    Suzanne Tharin

    Associate Professor of Neurosurgery
    On Partial Leave from 10/16/2023 To 06/30/2024

    Current Research and Scholarly InterestsThe long-term goal of my research is the repair of damaged corticospinal circuitry. Therapeutic regeneration strategies will be informed by an understanding both of corticospinal motor neuron (CSMN) development and of events occurring in CSMN in the setting of spinal cord injury. MicroRNAs are small, non-coding RNAs that regulate the expression of “suites” of genes. The work in my lab seeks to identify microRNA controls over CSMN development and over the CSMN response to spinal cord injury.

  • Reena Thomas, MD PhD

    Reena Thomas, MD PhD

    Clinical Associate Professor, Neurology & Neurological Sciences
    Clinical Associate Professor (By courtesy), Neurosurgery

    Current Research and Scholarly Interests-Neuro Oncology Immunotherapy
    -Health Equity
    -Medical Education

  • Zachary David Threlkeld

    Zachary David Threlkeld

    Clinical Associate Professor, Neurology & Neurological Sciences
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Threlkeld cares for critically ill patients with acute neurologic illness, including traumatic brain injury, stroke, intracerebral hemorrhage, and epilepsy. He completed his residency training in neurology at the University of California, San Francisco, and joined the Stanford Neurocritical Care program after completing fellowship training in neurocritical care at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. He has a particular clinical and research interest in traumatic brain injury. His research uses advanced imaging modalities like functional magnetic resonance imaging (fMRI) to better understand disorders of consciousness.

  • Maxine Umeh Garcia

    Maxine Umeh Garcia

    Instructor, Neurosurgery

    BioMaxine was born and raised in Sacramento, CA and transferred to UC Merced in 2007 after attending a community college for 2 years. She received her B.S. in Developmental Biology with a minor in Psychology in 2010. During the last year of her undergrad, Maxine was invited to do research in the lab of Dr. Michael Cleary, studying nervous system development. Because of this research experience, Maxine decided to stay at UC Merced to pursue her Master’s in Quantitative and Systems Biology, graduating in 2013. Immediately after graduating, she started her Ph.D. at UC Davis, where her research centered on triple negative breast cancer – a type of breast cancer that has a high incidence in Black and African women.

    After completing her PhD in Biochemistry, Molecular, Cell and Developmental Biology with an emphasis in Translational Research in 2019, Maxine became a postdoctoral fellow at Stanford University in the department of Neurosurgery. Dr. Umeh Garcia’s research focuses on breast cancers that metastasize (or travel) to the brain. Maxine was recently promoted to an instructor position in her department after receiving a major career development award from the National Cancer Institute (K99/R00), which will fund the remainder of her postdoctoral research and provide 3 years of funding for Maxine to establish her own independent research lab. Using her background in bench research, informatics, and translational research, Dr. Umeh Garcia hopes to bring together biologists, data scientists, and clinicians to make important advances in breast cancer diagnosis and treatment. Additionally, as a women and underrepresented minority, Dr. Umeh Garcia is keenly interested in mentoring women and underrepresented students, and in developing novel strategic approaches to increasing diversity in biomedical sciences and academic research.

  • Anand Veeravagu

    Anand Veeravagu

    Associate Professor of Neurosurgery and, by courtesy, of Orthopaedic Surgery

    Current Research and Scholarly InterestsThe focus of my laboratory is to utilize precision medicine techniques to improve the diagnosis and treatment of neurologic conditions. From traumatic brain injury to spinal scoliosis, the ability to capture detailed data regarding clinical symptoms and treatment outcomes has empowered us to do better for patients. Utilize data to do better for patients, that’s what we do.

    Stanford Neurosurgical Ai and Machine Learning Lab
    http://med.stanford.edu/neurosurgery/research/AILab.html

  • Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS

    Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS

    Clinical Professor, Neurology & Neurological Sciences
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsI am interested in the study of the radiological characteristics and temporal profile of edema/ tissue injury in the perihematomal area around spontaneous intracerebral hemorrhage. I am also interested in developing protocols for emergent reversal of anticoagulation in a life-threatening hemorrhage situation.

  • Hannes Vogel MD

    Hannes Vogel MD

    Professor of Pathology and of Pediatrics (Pediatric Genetics) and, by courtesy, of Neurosurgery, Neurology and of Comparative Medicine

    Current Research and Scholarly InterestsMy research interests include nerve and muscle pathology, mitochondrial diseases, pediatric neurooncology, and transgenic mouse pathology.

  • Xinnan Wang

    Xinnan Wang

    Associate Professor of Neurosurgery

    Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.

  • Thomas J. Wilson

    Thomas J. Wilson

    Clinical Associate Professor, Neurosurgery

    BioDr. Thomas J. Wilson was born in Omaha, Nebraska. He attended the University of Nebraska College of Medicine, earning his MD with highest distinction. While a medical student, he was awarded a Howard Hughes Medical Institute Research Training Fellowship and spent a year in the lab of Dr. Rakesh Singh at the University of Nebraska. He was also elected to the prestigious Alpha Omega Alpha Honor Medical Society. He completed his residency training in neurological surgery at the University of Michigan and was mentored by Dr. Lynda Yang and Dr. John McGillicuddy in peripheral nerve surgery. Following his residency, he completed a fellowship in peripheral nerve surgery at the Mayo Clinic in Rochester, Minnesota, working with Dr. Robert Spinner. He is now Clinical Associate Professor and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University. He also holds a Master of Public Health (MPH) degree from the Bloomberg School of Public Health at Johns Hopkins University, with focused certificates in Clinical Trials and Health Finance and Management. His research interests include peripheral nerve outcomes research, clinical trials advancing options for patients with peripheral nerve pathologies and spinal cord injuries, and translational research focused on improved imaging techniques to assist in diagnosing nerve pain and other peripheral nerve conditions. His clinical practice encompasses the treatment of all peripheral nerve pathologies, including entrapment neuropathies, nerve tumors, nerve injuries (including brachial plexus injuries, upper and lower extremity nerve injuries), and nerve pain. Dr. Wilson enjoys working in multi-disciplinary teams to solve complex problems of the peripheral nervous system. His wife, Dr. Monique Wilson, is a practicing dermatologist in the Bay Area.

  • Albert J. Wong, M.D.

    Albert J. Wong, M.D.

    Professor of Neurosurgery
    On Leave from 01/01/2024 To 05/30/2024

    Current Research and Scholarly InterestsOur goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.